Expanded recall for Franck's Compounds

Share this article:

The FDA is notifying all physicians and healthcare organizations of the recall of all sterile products sold by Franck's Compounding Pharmacy since November 2011 due to the possibility of lack of sterility.

In March 19, 2012, FDA received reports of fungal endophthalmitis in patients who were given Brilliant Blue G (BBG), supplied by Franck's Pharmacy, during eye surgeries. In April 20, 2012, FDA received reports of eye infections in patients who were given injections of Franck's drug products containing triamcinolone acetonide during eye surgery.

An active investigation by the CDC and FDA is ongoing at this time. FDA advises that any product received from Franck's since November 2011 not be used.

For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305592.htm.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

Antimicrobials commonly prescribed for acute respiratory tract infections

Antimicrobials commonly prescribed for acute respiratory tract infections

Antimicrobial agents were prescribed in 56.9% of acute respiratory tract infections encounters, representing an estimated 11.4 million potentially preventable antimicrobial prescriptions.

HPV knowledge doesn't predict vaccine compliance

HPV knowledge doesn't predict vaccine compliance

After surveying low-income communities, researchers found that human papillomavirus knowledge did not sway vaccination compliance.

Poverty linked to increased respiratory-related hospitalizations

Poverty linked to increased respiratory-related hospitalizations

Low income patients had nearly three times the odds of hospitalization compared with high income patients.